サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1525927

乳児臨床栄養市場：世界の産業分析、規模、シェア、成長、動向、予測、2024～2033年

Infant Clinical Nutrition Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 159 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
乳児臨床栄養市場：世界の産業分析、規模、シェア、成長、動向、予測、2024～2033年
出版日: 2024年07月19日
発行: Persistence Market Research
ページ情報: 英文 159 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、乳児臨床栄養学の世界市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題を含む重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主な洞察

  • 乳児臨床栄養学の市場規模（2024E）：274億9,180万米ドル
  • 市場予測値（2033F）：457億3,370万米ドル
  • 世界市場成長率（CAGR 2024年から2033年まで）：5.8%

乳児臨床栄養市場- レポート範囲：

乳児臨床栄養は、新生児と乳児の健康と発達をサポートする上で、世界的に重要な役割を果たしています。この市場には、乳児用調製粉乳、ベビーフード、栄養補助食品など、乳児専用に設計された幅広い栄養製品が含まれます。この市場の主な利害関係者には、メーカー、ヘルスケアプロバイダー、規制機関などがあり、それぞれが市場の成長と規制の枠組みに貢献しています。

市場成長の促進要因：

世界の乳児臨床栄養市場は、出生率の増加、幼児期の栄養の重要性に対する意識の高まり、栄養科学の進歩など、いくつかの主要な要因によって牽引されています。乳糖不耐症、アレルギー、早産合併症など、さまざまな健康状態に対応する乳児用特殊粉ミルクへの需要が市場拡大の原動力となっています。さらに、健康志向の親たちの間で有機・自然乳幼児用食品の採用が拡大していることも、市場の成長をさらに刺激しています。

市場抑制要因：

有望な成長見通しとは裏腹に、乳児臨床栄養学市場は、特に製品の安全性、表示、宣伝文句に関する厳しい規制要件に関連する課題に直面しています。さらに、景気変動、価格圧力、サプライチェーンの混乱は市場力学に影響を与え、持続的な収益性と市場拡大を目指す市場プレイヤーに課題を突きつけています。

市場機会：

乳幼児臨床栄養市場は、人口動向、食生活の嗜好の進化、栄養研究の進歩によって大きな成長機会がもたらされます。低アレルギー用調製粉乳やプロバイオティクス強化ベビーフードなどの製品処方の革新は、より健康的で機能的な乳児栄養オプションに対する消費者の新たな需要に応えるものです。メーカー、医療提供者、栄養士間の戦略的協力は、エビデンスに基づく栄養ソリューションの開拓と多様な人口層への市場拡大において極めて重要です。

本レポートで扱う主な質問

  • 乳児臨床栄養市場の世界の成長を促進する主な要因は何か？
  • 親やヘルスケアプロバイダーの間で採用が増加している製品セグメントと栄養製剤は何か？
  • 規制状況や消費者の嗜好は乳児臨床栄養学市場の競合情勢をどのように形成しているか？
  • 乳児臨床栄養学市場に貢献している主要企業はどこか、また、市場のリーダーシップを維持するためにどのような戦略をとっているのか？
  • 世界の乳児臨床栄養学市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限

第3章 主要な市場動向

  • 市場に影響を与える主な動向
    • 出生率の上昇と早産の増加により、乳児栄養補助食品の必要性が高まっている
    • 乳児用食品の栄養改良の進歩が市場の成長を促進
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 製品の採用/使用状況分析
  • 製品のUSP/特徴
  • 戦略的プロモーション戦略

第5章 世界の乳児臨床栄養市場- 価格分析

  • 地域別価格動向分析、2019～2023年
  • 世界平均価格分析ベンチマーク

第6章 世界の乳児臨床栄養市場の需要（価値百万米ドル）分析

  • 過去の市場金額（百万米ドル）分析、2019～2023年
  • 現在および将来の市場金額（百万米ドル）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第7章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 世界の食品・飲料業界の概要
  • 世界の乳製品業界の概要
  • サプライチェーンとバリューチェーン分析
  • 政策の展開と規制のシナリオ
  • 市場力学
  • 世界需給分析

第8章 世界の乳児臨床栄養市場分析：製品タイプ

  • イントロダクション/主な調査結果
  • 過去の市場規模（百万米ドル）、製品タイプ別、2019～2023年年
  • 現在および将来の市場規模（百万米ドル）と分析および予測、製品タイプ別、2024～2033年
    • ミルクベース
    • 大豆ベース
    • オーガニック
    • プロバイオティクス/プレバイオティクス
  • 製品タイプ別の市場の魅力分析

第9章 世界の乳児臨床栄養市場分析：投与経路別

  • イントロダクション/主な調査結果
  • 市場規模（百万米ドル）と数量分析別、投与経路別、2019～2023年
  • 現在および将来の市場規模（百万米ドル）と数量分析および予測、投与経路別、2024～2033年
    • 経口投与
    • 経腸投与
    • 静脈内投与
  • 投与経路別の市場の魅力分析

第10章 世界の乳児臨床栄養市場分析：地域別

  • イントロダクション
  • 市場規模（百万米ドル）と数量分析、地域別、2019～2023年
  • 現在の市場規模（百万米ドル）と数量分析および予測、地域別、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジアおよび太平洋
    • 東アジア
    • 中東およびアフリカ
  • 地域別の市場の魅力分析

第11章 北米の乳児臨床栄養市場分析

第12章 ラテンアメリカの乳児臨床栄養市場分析

第13章 欧州の乳児臨床栄養市場分析

第14章 南アジアおよび太平洋地域の乳児臨床栄養市場分析

第15章 東アジアの乳児臨床栄養市場分析

第16章 中東およびアフリカの乳児臨床栄養市場分析

第17章 国別の乳児臨床栄養市場分析、2024年

  • イントロダクション
  • 米国
  • カナダ
  • メキシコ
  • ブラジル
  • アルゼンチン
  • ドイツ
  • イタリア
  • フランス
  • 英国
  • スペイン
  • ポーランド
  • ロシア
  • 中国
  • 日本
  • 韓国
  • インド
  • オセアニア（オーストラリア、ニュージーランド）
  • トルコ
  • 南アフリカ

第18章 市場構造分析

  • 企業階層別市場分析（乳児臨床栄養）
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第19章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Abbott Laboratories
    • Baxter International
    • Nestle SA
    • Danone
    • Meiji Holdings Co., Ltd.
    • Fresenius SE &Co. KGaA
    • Reckitt Benckiser Group Plc
    • Perrigo Co. Plc
    • Ingredion Inc.
    • Solace Nutrition
    • Others（on Additional Request）

第20章 使用される仮定と頭字語

第21章 調査手法

目次
Product Code: PMRREP22363

Persistence Market Research has recently released a comprehensive report on the worldwide market for infant clinical nutrition. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Infant Clinical Nutrition Market Size (2024E): USD 27491.8 Mn
  • Projected Market Value (2033F): USD 45733.7 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.8%

Infant Clinical Nutrition Market - Report Scope:

Infant clinical nutrition plays a critical role in supporting the health and development of newborns and infants globally. This market encompasses a wide range of nutritional products designed specifically for infants, including infant formula, baby food, and nutritional supplements. Key stakeholders in this market include manufacturers, healthcare providers, and regulatory bodies, each contributing to the market's growth and regulatory framework.

Market Growth Drivers:

The global infant clinical nutrition market is driven by several key factors, including increasing birth rates, rising awareness about the importance of early childhood nutrition, and advancements in nutritional science. The demand for specialized infant formulas catering to various health conditions such as lactose intolerance, allergies, and preterm birth complications fuels market expansion. Moreover, the growing adoption of organic and natural infant food products among health-conscious parents further stimulates market growth.

Market Restraints:

Despite promising growth prospects, the infant clinical nutrition market faces challenges related to stringent regulatory requirements, particularly concerning product safety, labeling, and advertising claims. Additionally, economic fluctuations, pricing pressures, and supply chain disruptions impact market dynamics, posing challenges for market players aiming for sustained profitability and market expansion.

Market Opportunities:

The infant clinical nutrition market presents significant growth opportunities driven by demographic trends, evolving dietary preferences, and advancements in nutritional research. Innovations in product formulations, such as hypoallergenic formulas and probiotic-enriched baby foods, cater to emerging consumer demands for healthier and functional infant nutrition options. Strategic collaborations between manufacturers, healthcare providers, and nutritionists are crucial in developing evidence-based nutritional solutions and expanding market reach across diverse demographic segments.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the infant clinical nutrition market globally?
  • Which product segments and nutritional formulations are witnessing increased adoption among parents and healthcare providers?
  • How are regulatory developments and consumer preferences shaping the competitive landscape of the infant clinical nutrition market?
  • Who are the key players contributing to the infant clinical nutrition market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global infant clinical nutrition market?

Competitive Intelligence and Business Strategy:

Leading players in the global infant clinical nutrition market, including Nestle S.A., Abbott Laboratories, Danone S.A., Mead Johnson Nutrition Company, and Reckitt Benckiser Group plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce new nutritional products tailored to specific health needs and consumer preferences. Collaborations with pediatricians, hospitals, and retail channels enhance product distribution and market penetration, ensuring comprehensive infant nutrition solutions globally.

Key Companies Profiled:

  • Abbott Laboratories
  • Baxter International Inc.
  • Nestle S.A.
  • Danone
  • Meiji Holdings Co., Ltd.,
  • Fresenius SE & Co. KGaA
  • Reckitt Benckiser Group Plc
  • Perrigo Co. Plc
  • Ingredion Inc.
  • Solace Nutrition

Infant Clinical Nutrition Industry Research by Category

By Product Type:

  • Milk-Based
  • Soy-Based
  • Organic
  • Probiotic/Prebiotic

By Route of Administration:

  • Oral administration
  • Enteral administration
  • Intravenous administration

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
    • 3.1.1. Increasing Birth Rate with the Growing Number of Premature Births Creates Needs for Infant Nutrition Supplements
    • 3.1.2. Advancements in the Nutritional Modifications in the Infant Food Products to Boost the Market Growth
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic Promotional Strategies

5. Global Infant Clinical Nutrition Market - Pricing Analysis

  • 5.1. Regional Pricing Trend Analysis, 2019-2023
  • 5.2. Global Average Pricing Analysis Benchmark

6. Global Infant Clinical Nutrition Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

  • 7.1. Macro-Economic Factors
    • 7.1.1. Global GDP Growth Outlook
    • 7.1.2. Global Food & Beverage industry Overview
    • 7.1.3. Global GDP and Infrastructure Investment
    • 7.1.4. International Trade
    • 7.1.5. Global Industry Outlook
  • 7.2. Forecast Factors - Relevance & Impact
    • 7.2.1. Top Companies Historical Growth
    • 7.2.2. GDP Growth forecast
    • 7.2.3. Manufacturing Industry forecast
    • 7.2.4. Global Urbanization Growth Outlook
    • 7.2.5. Business Climate
  • 7.3. Global Food and Beverage Industry Overview
  • 7.4. Global Dairy Industry Overview
  • 7.5. Supply Chain & Value-Chain Analysis
    • 7.5.1. Raw Material Suppliers
    • 7.5.2. Product Manufacturers
    • 7.5.3. Distribution Channel Industries
  • 7.6. Policy Developments and Regulatory Scenario
    • 7.6.1. The United States Food and Drug Administration (FDA)
    • 7.6.2. Canadian Food Inspection Agency
    • 7.6.3. European Food Safety Authority (EFSA)
    • 7.6.4. The Food Safety and Standards Authority of India (FSSAI)
    • 7.6.5. Ministry of Health, Labor and Welfare. (MHLW), Japan
    • 7.6.6. National Health Commission (NHC), China
    • 7.6.7. Food Standards Australia New Zealand (FSANZ)
  • 7.7. Market Dynamics
    • 7.7.1. Drivers
    • 7.7.2. Restraints
    • 7.7.3. Opportunity Analysis
  • 7.8. Global Supply Demand Analysis

8. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) By Product Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2033
    • 8.3.1. Milk-Based
    • 8.3.2. Soy-Based
    • 8.3.3. Organic
    • 8.3.4. Probiotic/Prebiotic
  • 8.4. Market Attractiveness Analysis By Product Type

9. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, By Route of Administration

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis By Route of Administration, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Route of Administration, 2024-2033
    • 9.3.1. Oral administration
    • 9.3.2. Enteral administration
    • 9.3.3. Intravenous administration
  • 9.4. Market Attractiveness Analysis By Route of Administration

10. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
  • 10.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. South Asia and Pacific
    • 10.3.5. East Asia
    • 10.3.6. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 11.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 11.4.1. By Country
      • 11.4.1.1. U.S.
      • 11.4.1.2. Canada
    • 11.4.2. By Product Type
    • 11.4.3. By Route of Administration
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Product Type
    • 11.5.3. By Route of Administration
  • 11.6. Market Trends
  • 11.7. Key Market Participants - Intensity Mapping
  • 11.8. Drivers and Restraints - Impact Analysis

12. Latin America Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 12.4.1. By Country
      • 12.4.1.1. Brazil
      • 12.4.1.2. Mexico
      • 12.4.1.3. Argentina
      • 12.4.1.4. Rest of Latin America
    • 12.4.2. By Product Type
    • 12.4.3. By Route of Administration
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Product Type
    • 12.5.3. By Route of Administration
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Europe Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 13.4.1. By Country
      • 13.4.1.1. Germany
      • 13.4.1.2. Italy
      • 13.4.1.3. France
      • 13.4.1.4. U.K.
      • 13.4.1.5. Spain
      • 13.4.1.6. BENELUX
      • 13.4.1.7. Russia
      • 13.4.1.8. Poland
      • 13.4.1.9. Rest of Europe
    • 13.4.2. By Product Type
    • 13.4.3. By Route of Administration
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By Route of Administration
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. South Asia and Pacific Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. India
      • 14.4.1.2. ASEAN
      • 14.4.1.3. Oceania (Australia & New Zealand)
      • 14.4.1.4. Rest of South Asia & Pacific
    • 14.4.2. By Product Type
    • 14.4.3. By Route of Administration
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By Route of Administration
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. East Asia Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. China
      • 15.4.1.2. Japan
      • 15.4.1.3. South Korea
    • 15.4.2. By Product Type
    • 15.4.3. By Route of Administration
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By Route of Administration
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Middle East and Africa Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 16.4.1. By Country
      • 16.4.1.1. GCC Countries
      • 16.4.1.2. Turkey
      • 16.4.1.3. Northern Africa
      • 16.4.1.4. South Africa
      • 16.4.1.5. Rest of Middle East and Africa
    • 16.4.2. By Product Type
    • 16.4.3. By Route of Administration
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product Type
    • 16.5.3. By Route of Administration
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Country Wise Infant Clinical Nutrition Market Analysis, 2024

  • 17.1. Introduction
    • 17.1.1. Market Value Proportion Analysis, By Key Countries
    • 17.1.2. Global Vs. Country Growth Comparison
  • 17.2. U.S. Infant Clinical Nutrition Market Analysis
    • 17.2.1. By Product Type
    • 17.2.2. By Route of Administration
  • 17.3. Canada Infant Clinical Nutrition Market Analysis
    • 17.3.1. By Product Type
    • 17.3.2. By Route of Administration
  • 17.4. Mexico Infant Clinical Nutrition Market Analysis
    • 17.4.1. By Product Type
    • 17.4.2. By Route of Administration
  • 17.5. Brazil Infant Clinical Nutrition Market Analysis
    • 17.5.1. By Product Type
    • 17.5.2. By Route of Administration
  • 17.6. Argentina Infant Clinical Nutrition Market Analysis
    • 17.6.1. By Product Type
    • 17.6.2. By Route of Administration
  • 17.7. Germany Infant Clinical Nutrition Market Analysis
    • 17.7.1. By Product Type
    • 17.7.2. By Route of Administration
  • 17.8. Italy Infant Clinical Nutrition Market Analysis
    • 17.8.1. By Product Type
    • 17.8.2. By Route of Administration
  • 17.9. France Infant Clinical Nutrition Market Analysis
    • 17.9.1. By Product Type
    • 17.9.2. By Route of Administration
  • 17.10. U.K. Infant Clinical Nutrition Market Analysis
    • 17.10.1. By Product Type
    • 17.10.2. By Route of Administration
  • 17.11. Spain Infant Clinical Nutrition Market Analysis
    • 17.11.1. By Product Type
    • 17.11.2. By Route of Administration
  • 17.12. Poland Infant Clinical Nutrition Market Analysis
    • 17.12.1. By Product Type
    • 17.12.2. By Route of Administration
  • 17.13. Russia Infant Clinical Nutrition Market Analysis
    • 17.13.1. By Product Type
    • 17.13.2. By Route of Administration
  • 17.14. China Infant Clinical Nutrition Market Analysis
    • 17.14.1. By Product Type
    • 17.14.2. By Route of Administration
  • 17.15. Japan Infant Clinical Nutrition Market Analysis
    • 17.15.1. By Product Type
    • 17.15.2. By Route of Administration
  • 17.16. S. Korea Infant Clinical Nutrition Market Analysis
    • 17.16.1. By Product Type
    • 17.16.2. By Route of Administration
  • 17.17. India Infant Clinical Nutrition Market Analysis
    • 17.17.1. By Product Type
    • 17.17.2. By Route of Administration
  • 17.18. Oceania (Australia and New Zealand) Infant Clinical Nutrition Market Analysis
    • 17.18.1. By Product Type
    • 17.18.2. By Route of Administration
  • 17.19. Turkey Infant Clinical Nutrition Market Analysis
    • 17.19.1. By Product Type
    • 17.19.2. By Route of Administration
  • 17.20. South Africa Infant Clinical Nutrition Market Analysis
    • 17.20.1. By Product Type
    • 17.20.2. By Route of Administration

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies (Infant Clinical Nutrition)
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Abbott Laboratories
      • 19.3.1.1. Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.1.4. Sales Footprint
      • 19.3.1.5. Strategy Overview
    • 19.3.2. Baxter International
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.2.4. Sales Footprint
      • 19.3.2.5. Strategy Overview
    • 19.3.3. Nestle S.A.
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.3.4. Sales Footprint
      • 19.3.3.5. Strategy Overview
    • 19.3.4. Danone
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.4.4. Sales Footprint
      • 19.3.4.5. Strategy Overview
    • 19.3.5. Meiji Holdings Co., Ltd.
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.5.4. Sales Footprint
      • 19.3.5.5. Strategy Overview
    • 19.3.6. Fresenius SE & Co. KGaA
      • 19.3.6.1. Overview
      • 19.3.6.2. Product Portfolio
      • 19.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.6.4. Sales Footprint
      • 19.3.6.5. Strategy Overview
    • 19.3.7. Reckitt Benckiser Group Plc
      • 19.3.7.1. Overview
      • 19.3.7.2. Product Portfolio
      • 19.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.7.4. Sales Footprint
      • 19.3.7.5. Strategy Overview
    • 19.3.8. Perrigo Co. Plc
      • 19.3.8.1. Overview
      • 19.3.8.2. Product Portfolio
      • 19.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.8.4. Sales Footprint
      • 19.3.8.5. Strategy Overview
    • 19.3.9. Ingredion Inc.
      • 19.3.9.1. Overview
      • 19.3.9.2. Product Portfolio
      • 19.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.9.4. Sales Footprint
      • 19.3.9.5. Strategy Overview
    • 19.3.10. Solace Nutrition
      • 19.3.10.1. Overview
      • 19.3.10.2. Product Portfolio
      • 19.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.10.4. Sales Footprint
      • 19.3.10.5. Strategy Overview
    • 19.3.11. Others ( on Additional Request)
      • 19.3.11.1. Overview
      • 19.3.11.2. Product Portfolio
      • 19.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.11.4. Sales Footprint
      • 19.3.11.5. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology